Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of S-1 plus leucovorin in advanced cholangiocarcinoma
TCTR20160313001Phase 2Completed
- Sponsor
- Chulabhorn Hospital
- Start
- Nov 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, folinic acid in cholangiocarcinoma (CCA), sponsored by Chulabhorn Hospital. Started Nov 2015; status: completed.
02
Drugs
tegafurfolinic acid
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on TCTR20160313001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160313001.